LAGUNA HILLS, Calif. / Nov 07, 2023 / Business Wire / Sonendo, Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced that management will participate in three upcoming investor conferences in November.
Sonendo management is scheduled to present at the Stifel 2023 Healthcare Conference on Tuesday, November 14th at 6:10 a.m. Pacific Time / 9:10 a.m. Eastern Time.
Sonendo management is scheduled to present at the 2023 Sidoti Micro Cap Conference on Wednesday, November 15th at 1:00 p.m. Pacific Time / 4:00 p.m. Eastern Time.
Sonendo management is scheduled to present at the 35th Annual Piper Sandler Healthcare Conference on Wednesday, November 29th at 11:30 a.m. Pacific Time / 2:30 p.m. Eastern Time.
A webcast of each presentation will be available on the “Investors” section of the company’s website at: investor.sonendo.com.
About Sonendo
Sonendo is a commercial-stage medical technology company focused on saving teeth from tooth decay, the most prevalent chronic disease globally. Sonendo develops and manufactures the GentleWave® System, an innovative technology platform designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The system utilizes a proprietary mechanism of action, which combines procedure fluid optimization, broad-spectrum acoustic energy and advanced fluid dynamics, to debride and disinfect deep regions of the complex root canal system in a less invasive procedure that preserves tooth structure. The clinical benefits of the GentleWave System when compared to conventional methods of root canal therapy include improved clinical outcomes, such as superior cleaning that is independent of root canal complexity and tooth anatomy, high and rapid rates of healing and minimal to no post-operative pain. In addition, the GentleWave System can improve the workflow and economics of dental practices. Sonendo is also the parent company of TDO Software, the developer of widely used endodontic practice management software solutions, designed to simplify practice workflow. TDO Software integrates practice management, imaging, referral reporting and CBCT imaging, and offers built-in communication with the GentleWave System.
For more information on Sonendo, visit www.sonendo.com. For more information on the GentleWave System, visit www.gentlewave.com/doctor.
Last Trade: | US$0.03 |
Daily Volume: | 0 |
Market Cap: | US$2.110M |
November 08, 2023 October 17, 2023 September 28, 2023 |
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MOREImmix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB